Friday, April 22, 2016

NicCheck Being Used Once Again As The Evidence Based Test For 2016 Quit & Win Contest


                                                   MEDIA RELEASE

In both Europe and United States cardiovascular diseases caused by smoking are the most numerous group from those preventable through healthy lifestyle choices.
             In 2014 Romania current smoking prevalence was 27%, decreasing with 3% as compared to 2012, but still with 1% above the European Union average. In the general population, ex-smokers prevalence was 13%.

             QUIT & WIN is an international campaign of smoking cessation organized in Romania since 2000 by the National Institute of Public Health (INSP) in partnership with the Association for Health, Education and Family (ASEF).

            Q&W proposes to daily smoker adults abstaining from tobacco between May 2nd and 29th. Participants are supported technically and morally during abstinence, and those who succeed qualify for a drawing of important prizes held by World No Tobacco Day on  May 31st.
The 2016 Campaign,  IX edition, features 2 prizes of  USD 1000 value each, consisting of two 11 days double sojourns at Health Centers Herghelia -Mures and Podis - Bacau. Additional awards are granted to healthcare professionals consisting of subscriptions to prestigious publications such as Viata Medicala (Medical Life) or British Medical Journal - Romanian edition. Campaign supporters – nonsmokers who enroll participants - will also enjoy prizes in kind of  health & prevention books offered by the Life and Health Publishing House (EVS).

             A checking of "tobacco free" status will be for sure applied to prize-candidates among those designated as winners by drawing, namely: testing of cotinine in urine, and a by-honor-statement of a witness. The stripes for testing presence of cotinine in urine are generously offered free of any charge to Q&W Romania since 2004 by Don Mossman&Associates (USA) to whom we express our full gratitude.

             National Institute of Public Health in Bucharest, ASEF and EVS lead a coalition bringing together county Departments of Public Health (DSP), family doctors, pulmonologists, pharmacists, antismoke associations, youth associations - that will distribute enrollment forms to a public as numerous as possible - with the objective to encourage many smokers to quit for good.

             Enrollment  forms can be downloaded from www.viatasisanatate.ro, www.sanatateplus.ro, www.asef.ro websites or can be personally picked up from INSP, 1-3 Dr. Leonte Street (in  University Hospital - University of Medicine & Pharmacy - INSP triangle, Cotroceni quarter) or from DSP county offices.

Before last decade of Quit & Win 2016 enrollment we address smokers who oscillates between YES and NO to seize this opportunity for tilting the balance of their lives towards LIFE AND HEALTH.

 Prof. dr. Radu Negoescu              Nicolae Florea                        Laura Vaţe

  National   Coordonator           ASEF Coordonator               EVS Coordonator 
 

Wednesday, August 19, 2015

MOSSMAN ASSOCIATES ANNOUNCES IT HAS BECOME THE NORTHEAST REPRESENTATIVE FOR BIOSOUND HEALING THERAPY

BioSound Healing Therapy is a novel product to keep people going through dependency programs to remain in them during those anxious times, reducing AMAs.

Milford, MA   May 15, 2015
Mossman Associates Inc is pleased to announce that we have become the Northeast representative for BioSound Healing Therapy. 

BioSound Healing Therapy is a product that integrates Biofeedback, Music Therapy, Sound Frequency Healing (Binaural Beats, Solfeggio frequencies and Charqes Tones) and Guided Imagery all centered around a Sound Massage, lounge style bed. 

The therapy uses full frequency sound to perform the massage which reduces stress and anxiety, promotes better sleep, reduces muscle tension and relieves withdrawal symptoms (especially pain), and reduces AMAs in treatment centers.  The therapy can be reimbursable by insurance, as our experience has shown in Florida at a low of $100 to a high of $200 per session.  The unit can be purchased, leased or rented so that you could be generating cash flow right from day 1 and the total cost of the therapy could be paid for by eliminating just 1 AMA. 

Don Mossman President of Mossman Associates is quoted as saying, “We are delighted to add this technology to our other products used in the in the treatment of drug, nicotine and alcohol addiction.  We have experience the positive effect that this technology can provide as well as witnessing it out in the field. 

About Mossman Associates, Inc.
Mossman Associates, Inc is a privately held medical device company that specializes in rapid tests for physicians and researchers as well as equipment and reagents for the biotech industry.  Incorporated in 2001 the professionals at Mossman Associates Inc have been involved with cutting edge technology for over 30 years.



Mossman Associates Inc. Announces the Availability of CO Check, An Essential Tool For Smoking Cessation and Nicotine Research

The CO Check is an innovative smoking cessation tool designed specifically for smoking cessation programs and nicotine research.

Milford, MA   June 23, 2015
Mossman Associates Inc is pleased to announce the availability of CO Check for those involved with Smoking Cessation programs and nicotine research.  One single breath of expiration into the CO Check provides instant results in PPM and % COHB via the large easy –to-read display.

The product for under $600 is used when a person attending a smoking cessation program first checks in to establish a baseline and then every visit after to monitor their progress.  Initially it serves as a gage of a person’s smoking status and then as a real proof of what they are doing is working.

CO Check along with NicCheck our dry chemistry dipstick for the semi-quantitative measurement of nicotine and nicotine metabolites in urine form a complete package of tests that can be used for a smoking cessation programs or nicotine research.
About Mossman Associates, Inc.

Mossman Associates, Inc is a privately held medical device company that specializes in rapid tests for physicians and researchers as well as equipment and reagents for the biotech industry.  Incorporated in 2001 the professionals at Mossman Associates Inc have been involved with cutting edge technology for over 30 years.

Monday, August 3, 2015

NicCheck to be used to confirm smoking cessation in the “Quit to Win Challenge” in Quebec Canada.

NicCheck test has been as the evidence based test to be used to confirm smoking cessation in the “Quit to Win Challenge” being held in Quebec Canada.


SMOKING ADDICTION.

Once again, Mossman Associates’ NicCheck test has been chosen to be the evidence based test used to confirm smoking cessation in the “Quit to Win Challenge” being held in Quebec Canada.  The 2015 edition of the “Quit to Win Challenge” annual campaign started on March 1st and will end on April 11th.  After that time winners will be selected and tested as they have done in previous years using our NicCheck product.

We are proud to continue our support of these types of contests”, quotes Donald Mossman, President of Mossman Associates. 
He continues, “Competitions like these in Romania, Canada, and Taiwan are instrumental in helping people break the smoking habit.  We look forward to working with other countries, universities and organizations that initiate on these types of programs”.

NicCheck is a dry chemistry dipstick for the semi-quantitative measurement of nicotine and nicotine metabolites in urine as an aid in the verification of a person’s true smoking status. This 15 minute test yields a semi-quantitative measurement of a person’s nicotine consumption based on the color intensity of the reaction found on the NicCheck test strips.

About Mossman Associates, Inc.

Mossman Associates, Inc is a privately held medical device company that specializes in rapid tests for physicians and researchers as well as equipment and reagents for the biotech industry.  Incorporated in 2001 the professionals at Mossman Associates Inc have been involved with cutting edge technology for over 30 years.


Wednesday, July 4, 2012

Winners Of The Romanian 2012 Quit&Win Contest Have Been Announced


Milford Ma, July 4, 2012-The Romanian 2012 Quit&Win Contest has concluded and winners are announced after being verified using NicCheck I test strips.
The Romanian 2012 Quit&Win Contest has concluded. This year the contest enrolled 273 participants and from these George Ghiorghisor of Calarasi and Mirela Barbu of Gaesti were identified as the 2 Grand Prize winners.
Participants went through a telephone screening process and then successful participants were validated through biomarker testing with NicCheck by entities such as Calarasi Public Health Authority and Gaesti Artic Plant Dispensary. The results were used to prove the winners were negative, non-smokers. The 2 Grand Prize winners will each receive a 2 persons (husband/wife), 11 day sojourn at the renown Life-Style Centers in Herghelia/Mures and Podis/Bacau respectively, valued at about $1000 each.

In addition, 4 people will be granted one year long subscriptions to British Medical Journal - Romanian Edition and Viata Medical (Medical Life) while the Publishing House Viata si Sanatate (Life & Health) will offer prizes in books and subscriptions to the Viata&Sanatate Magazine to the most active supporters.
The Romanian Quit&Win campaigns have persuaded thousands of people to quit smoking and NicCheck has been used since 2000 as the biomarker test to determine the ultimate winners.

NicCheck is a dry chemistry dipstick for the semi-quantitative measurement of nicotine and nicotine metabolites in urine as an aid in the verification of a person’s true smoking status. This 15 minute test yields a semi-quantitative measurement of a person’s nicotine consumption based on the color intensity of the reaction found on the NicCheck test strips.

Tuesday, April 24, 2012

Smoking Cessation Campaigns Around the World Using NicCheck to Confirm Success Once Again


Milford, Massachusetts; 4/24/2012 - Mossman Associates Inc. is pleased to announce that our NicCheck is being used once again within a number of Smoking Cessation Campaigns around the world.
Campaigns include: The John Tung Foundation in Taiwan, The Quit and Win Contest in Romania and The Quit to Win Challenge in Montreal, Canada. This represents consecutive years that we have been involved with these organizations and been a part of these well established campaigns.

Donald Mossman, President of Mossman Associates Inc. notes, "We are pleased to once again contribute to these programs which are designed to help those people trying to quit smoking. Our NicCheck product has been shown to be effective when used to monitor a person’s nicotine consumption as they reduce their nicotine dependence. 

Our test is simple and because it is a rapid visual test, it is conducive to being run in the field, lending itself nicely to smoking cessation programs as well as spot checks and remote health locations”.

For more information contact:

Donald Mossman, President
Mossman Associates Inc.
9 Village Circle
Milford, MA 01757
www.nicotinetesting.com
508-488-6169 (P)
don@mossmanassociates.com

Thursday, October 6, 2011

CLIAWAIVED.com signs distribution deal with Mossman Associates, and licenses global co-marketing rights to Mossman’s rapid nicotine testing technology

CLIAWAIVED.com announced the execution of an agreement for the exclusive US distribution and global co-marketing rights to Mossman’s NicCheck, rapid nicotine testing technology.


San Diego, CA, October 1, 2011

CLIAWAIVED.COM, Inc., the leading internet based, multi-line distributor of POC (point-of- care) CLIA waived Diagnostic tests in the US and Mossman Associates Inc., a leading diagnostic test manufacturer, today announced the execution of an agreement for the exclusive US distribution rights along with global co-marketing rights to Mossman’s NicCheck products and rapid nicotine testing technology.

CLIAwaived.com has agreed to pay Mossman Associates, Inc. an undisclosed fee for exclusive US license rights of NicCheck branded products along with the right to sell Mossman’s rapid nicotine testing products globally under CLIAwaived’s private label brand. Mossman’s NicCheck products are an ideal fit for the CLIAwaived.com portfolio of diagnostic products and will be marketed both in the US and globally with dozens of other rapid diagnostics. Specifically, this addition is strategically aimed at serving the growth-oriented point-of-care diagnostic markets including the increasingly growing need for waived tests in the physician office lab, addiction treatment and clinical research markets. At present, NicCheck is the only FDA Cleared and CLIA waived semi-quantitative instant nicotine test on the market that is CLIA compliant for these market segments.

Donald Mossman, President of Mossman Associates, Inc. said “we are pleased that CLIAWAIVED.COM has opted to become our exclusive distributor in the USA. Their position as the premier site for ordering CLIA waived test kits is a natural fit for our NicCheck product. Their site will offer our existing customers an internet option not currently available to them while exposing our product to a much larger customer base.”

Tim Drapeau, President of CLIAwaived, Inc. said, " I am delighted that Mossman Associates has chosen CLIAwaived.com to sell, distribute and market their NicCheck rapid nicotine testing products exclusively in the US POC market. As a company specializing in distributing CLIA compliant devices we believe the NicCheck product line will dominate our target markets and strengthen our position and portfolio of CLIA waived rapid diagnostics.”

About CLIAWAIVED.COM

CLIAWAIVED.COM, is a leading, Internet based, multi-line distributor of CLIA Waived, point-of-care diagnostic products to the healthcare industry. CLIAWAIVED’s portfolio of distributed products includes rapid diagnostics for early diagnosis and treatment of various diseases and conditions.

About Mossman Associates, Inc.

Mossman Associates, Inc. is a manufacturer and distributor of medical diagnostic test kits whose portfolio of products includes rapid onsite products for detection and screening of drugs of abuse, nicotine and alcohol as well as a serological test for tuberculosis.
Contact: CLIAWAIVED.COM
Mr. Tim Drapeau, President
CLIAwaived,Inc.
11578 Sorrento Valley Road
San Diego, CA 92121
www.cliawaived.com

OR

Mossman Associates, Inc.
Mr. Donald Mossman
9 Village Circle
Milford, MA 01757
www.mossmanassociates.com
508-488-6169